Last reviewed · How we verify
Drusen Morphology Changes in Nonexudative Age-related Degeneration Using Spectral Domain Optical Coherence Tomography After Oral Antioxidants Supplementation: One-year Results.
Purpose: To determine drusen morphology (volume and area) changes in nonexudative age-related macular degeneration (AMD) after one year of oral supplementation with AREDS-like formulation.
Details
| Lead sponsor | Germans Trias i Pujol Hospital |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 35 |
| Start date | 2013-01 |
| Completion | 2014-10 |
Conditions
- Macular Degeneration
Interventions
- Antioxidant
Primary outcomes
- Drusen volume change — 12 months